Intraoperative radiation therapy on pancreatic cancer patients: A review of the literature

Minerva Chirurgica

Volumn 66, Issue 4, 2011, Pages 361-369

  Zygogianni, G A ^a   Kyrgias, G ^b,c   Kouvaris, J ^a   Antypas, C ^a   Skarlatos, J ^c   Armpilia, C ^a   Nikiteas, N ^d   Kouloulias, E V ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c Radiotherapy Department   (Greece)

^d Surgery Ddt   (Greece)

Author keywords

Pancreatic neoplasms; Radiobiology; Radiotherapy

Indexed keywords

ADJUVANT THERAPY; HUMAN; INTRAOPERATIVE PERIOD; MORTALITY; PANCREAS TUMOR; PATHOLOGY; RADIOBIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURVIVAL; TREATMENT OUTCOME;

HUMANS; INTRAOPERATIVE PERIOD; PANCREATIC NEOPLASMS; RADIOBIOLOGY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 82755162886     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002, CA. Cancer J Clin 2005;55:74-108.
2. Abe M, Takahashi M, Yabumoto E et al. Clinical experiences with intraoperative radiotherapy of locally advanced cancers. Cancer 1980;45:40-8. (Pubitemid 10214952)
3. Willet G Christofer, Czito G. Brian, Tyler S. Douglas. Intraoperative Radiation therapy. Journal of Clinical Oncology,2007;25:971-7.
4. thedition), JB Lipincott, Philadelfia 2003; p. 428-567
5. Nag S, Gunderson L.L, Willett CG. Intraoperative irradiation with electron beam or high dose rate brachytherapy: methological comparison. In: Gunderson LL, Willett CG, Harrison LB, Calvo FA, editors. Intraoperative radiation. Techniques and results, Totowa, NJ: Humana Press; 1999- p. 111-30.
6. th edition. London: Hodder Arnold; 2006.
7. Guerrero M, Li X. Extending the linear quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol 2004;49:4825-35. (Pubitemid 39433509)
8. Wang J Z, Mayr Nn a, and Yu W T. A generalized linear quadratic formula for high dose rate brachytherapy and radiosurgery. Int. J. Radiât ONCOL. BIOL.Phys 2007;69;S619-S620.
9. Carlone M, Wilkins D, and Raaphorst G. The modified linear quadratic model of Guerrero and Li can be derived from mechanistic basis and exhibits linear quadratic linear behavior. Phys Med Biol 2005;50:L9-L15. (Pubitemid 40767808)
10. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics; 2000, CA. Cancer J Clin 2000;50:7-33.
11. National Cancer Institute. Pancreatic Cancer (PDQ): treatment. 2007 15.03.2007 [Internet]. Available from: www.cancer.gov [cited 2007, Apr 16].
12. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997;226:248-57.
13. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma Clinicopathologic analysis of 5-year survivors. Ann Surg 1990;223:273-9.
14. Trede M., Schwall G, Saeger HD. Survival after pancreatoduodenectomy 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447-58. (Pubitemid 20138186)
15. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993;165:68-72.
16. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 2003;237:74-85. (Pubitemid 36622320)
17. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchle MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. BrJ Surg 2004;91:586-94. (Pubitemid 38624667)
18. Yamaguchi K, Nakamura K, Kobayashi K, Nakano K, Koniomi H, Mizumoto K et al. ERT following IORT improves survival of patients with resectable pancreatic cancer, Hepatogastroenterology 2005;52:1244-9. (Pubitemid 40942225)
19. Gunderson LL, Tepper JE and Biggs DJ, Goldson A, Martin JK, McCullough EC et al. Intraoperative external beam irradiation. Curr Probl Cancer 1983;7:1-69.
20. rd edition. Philadelphia: JB Lippincott; 1997. p. 1467-88.
21. Gunderson LL, Nagorney DM, Martenson JA, Donohue JH, Garton GR, Nelson H et al. External beam plus intraoperative irradiation for gastrointestinal cancers. World J Surg 1995;19:191-7.
22. Willett CG, Del Castillo CF, Shih HA, Goldberg S, Biggs P, Clark JW et al. Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer. Ann Surg 2005;241:295-9.
23. O'Connor JK, Sause WT, Hazard LJ, Belnap LP, Noyes RD. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma. Int J Radiât Oncol Biol Phys 2005;63:1060-6. (Pubitemid 41505284)
24. Showalter TN, Rao AS, Rani Anne P, Rosato FE, Rosato EL, Andrei J et al. Does intraoperative radiation therapy improve local control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis. Ann Surg Oncol 2009,16-2116-22.
25. Reni M, Panucci MG, Ferreri AJ, Balzano G, Passoni P, Cattaneo GM et al. Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma, Int J Radiat Oncol Biol Phys 2001;50:651-8. (Pubitemid 32515322)
26. Calvo FA, Matute R, García-Sabrido JL, Gómez-Espí M, Martínez NE, Lozano MA et al. Neoadjuvant chemoradiation with tegafur in cancer of the pancreas: initial analysis of clinical tolerance and outcome. Am J Clin Oncol 2004;27:343-9-
27. Okamoto A, Tsuruta K, Karasawa K, Miyanari N, Matsumoto G, Kamisawa T et al. Resection versus palliation: treatment of stage III and IVA carcinomas of the pancreas employing intraoperative radiation. World J Surg 2003;27:599-605. (Pubitemid 36961134)
28. Shimizu Y, Yasui K, Fuwa N, Arai Y, Yamao K. Late complication in patients undergoing pancreatic resection with intraoperative radiation therapy: gastrointestinal bleeding with occlusion of the portal system, J Gastroenterol Hepatol 2005;20:1235-40. (Pubitemid 41602567)
29. Ma HB, Di ZL, Wang XJ, Kang HF, Deng HC, Bai MH. Effect of intraoperative radiotherapy combined with external beam radiotherapy following internal drainage for advanced pancreatic carcinoma, World J Gastroenterol 2004;10:1669-71.
30. Sunamura M, Karasawa K, Okamoto A, Ogata Y, Němoto K, Hosotani R et al. Phase III trial of radiosensitizer PR-350 combined with intraoperative radiotherapy for the treatment of locally advanced pancreatic cancer. Pancreas 2004;28:330-4. (Pubitemid 38437334)
31. Mohiuddin M, Regine WF, Stevens J, Rosato F, Barbot D, Biermann W et al. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas, J Clin Oncol 1995;13:2764-8.
32. Ogava K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H et al. Intraoperative radiotherapy for resected pancreatic cancer: a multi-istitutional retrospective analysis of 210 patients. Int J Radiât Oncol Biol Phys 2010;77:645-7.
33. Ogava K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H et al. Intraoperative radiotherapy for unresected pancreatic cancer: a multi-istitutional retrospective analysis of 144 patients. Int J Radiat Oncol Biol Phys 2010 [In press].
34. Takamori H, Hiraoka T, Kanemitsu K, Tsuji T, Hamada C, Baba H. Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer - under-analysis of cumulative survival curve. World J Surg 2006;30:213-8. (Pubitemid 43162493)
35. Hiraoka T, Kanemitsu K. Value of extended resection and intraoperative radiotherapy for resectable pancreatic cancer. World J Surg 1999;23:930-6. (Pubitemid 29398476)
36. Ihse I, Andersson R, Ask A, Ewers SB, Lindell G, Tranberg KG. Intraoperative radiotherapy for patients with carcinoma of the pancreas. Pancreatology 2005;5:438-42. (Pubitemid 41160284)
37. Furuse J, Kinoshita T, Kawashima M, Ishii H, Nagase M, Konishi M et al. Intraoperative and conformai external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma. Cancer 2003;97:1346-52. (Pubitemid 36237323)
38. Takahashi S, Aiura K, Saitoh J, Hayatsu S, Kitajima M, Ogata Y. Treatment strategy for pancreatic head cancer: pylorus-preserving pancreatoduodenectomy, intraoperative radiotherapy and portal catheterization. Digestion 1999;60:130-4. (Pubitemid 29110491)
39. Kasperk R, Klever P, Andreopoulos D, Schumpelick V. Intraoperative radiotherapy for pancreatic-carcinoma. Br J Surg 1995;82:1259-61.
40. Crane CH, Varadhachary G, Pisters PW, Evans DB, Wolff RA. Future chemoradiation strategies in pancreatic cancer. Semin Oncol 2007;34:335-46. (Pubitemid 47176616)
41. Sultana A, Tudur Smith C, Cunninghan D, Starling N, Tait D, Neoptolemos JP et al. Systematic review, including meta analyses, on the management of locally advanced pancreatic cancer using radiation combined modality therapy. Br J Cancer 2007;96:1183-93.
42. Yip D, Karapetis C, Strickland A, Steer CB, Goldstein D. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database Syst Rev 2006;3:CD002093.
43. Stocken DD, Büchler MW, Dervenis C, Bassi C, Jeekel H, Klinkenbijl JH et al. Meta-analysis of randomized adjuvant therapy trials for pancreatic cancer. Br J Cancer 2005;92:1372-81. (Pubitemid 40705002)
44. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Stocken DD, Tait DM et al. Adjuvant chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200.
45. White RR, Kaftan MW, Haney JC, Clary BM, Pappas TN, Tyler DS et al. Evaluation of preoperative therapy for pancreatic cancer using a prognostic monogram. Ann Surg Oncol 2006;13:1485-92. (Pubitemid 44749660)
46. Aristu J, Cañón R, Pardo F, Martínez-Monge R, MartinAlgarra S, Manuel Ordonez J et al. Surgical resection after preoperative chemotherapy benefits selected patients with unresectable pancreatic cancer. Am J Clin Oncol 2003;26:30-6. (Pubitemid 36205894)
47. Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP et al. Neoadjuvant chemotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 2001;8:123-32. (Pubitemid 32199408)
48. Macchia G, Valentini V, Morganti AG. Target motions in the determination of the internal margin (IM) in bilio-pancreatic carcinoma. Radiother Oncol 2002;64(Suppl D.S180.
49. Calvo FA, Meirino RM, de la Mata MD. In: Principles and practice of radiation oncology. Philadelphia: Halperin EC & Wilkins; 2008. p. 397-406.
50. Termuhlen PM, Evans DB, Willet CG. IORT in pancreatic carcinoma. In: Gunderson LL, Willett CG, Harrison LB, Calvo FA, editors. Intraoperative irradiation. Totowa: Humana Press; 1999. p. 201-23.
51. Valentini V, Morganti AG, Machia G, Mantini G, Mattiucci GC, Brizi MG et al. Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. Int J Radiat Oncol Biol Phys 2008;70:1094-9. (Pubitemid 351296100)
52. Almazan Ortega R, Guedea F, Ruano-Ravina A. Intraoperative radiotherapy in pancreatic cancer. A systematic review. Radiot Oncol 2008;7:318-25.
53. Update mastology. Mouzaka L, editor. Pasxalidis, Athens: Medical Press; 2006. p. 811-25.
54. Gallon G, Gunderson LL, Nagorney D, Donohue JH, Martin JK, Mcllrath DC et al. High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer. Int J Radiât Oncol Biol Phys 1993;27:1153.
55. Roldan GE, Gunderson LL, Nagorney DM, Martin JK, Ilstrup DM, Holbrook MA et al. External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer 1988;61:110.
56. Valentini V, Calvo F, Reni M, Krempien R, Sedlmayer F, Buchler MW et al. Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT- Europe experience Radiother Oncol 2009;91:54-9-